PEspeaks

Jul 06, 2016
It's time for new pharma strategies to combat deadly drug-resistant infections, writes Jil Wechsler.
Jul 01, 2016
Last month Microsoft bought LinkedIn. What does this mean for pharm execs using the platform? Peter Houston reports.
Jun 24, 2016
By Pharmaceutical Executive Editors
EU and UK industry groups did their best to display calm and confidence as the world woke up to the reality of Brexit.
Jun 23, 2016
Pharma's challenge is to break the cycle of mistrust so that its pioneering work can fully reach patients in need, writes GSK's CMO Murray Stewart.
Jun 20, 2016
From Applied Clinical Trials
Ken Getz of the Tufts Center for the Study of Drug Development outlines how the convergence of health data and technology will be key to lasting gains for clinical research.
Jun 20, 2016
Jill Wechsler on the need for more efficient methods of documenting treatment benefits in medical practice.
Jun 17, 2016
Pharmaceutical Executive
The World Medical Innovation Forum presents its second list of breakthrough technologies—this time focused on oncology.
Jun 14, 2016
Pharmaceutical Executive
William Looney explores the power of workplace aesthetic on the intangibles of culture, morale — and corporate mission.
Jun 03, 2016
California is in the process of potentially establishing a new, disruptive healthcare policy that is proving to be very concerning to the American Rx industry, writes Tom Norton.
May 31, 2016
Is Snapchat just for fun, or should pharma marketers be taking it seriously as a media platform? Peter Houston takes a look.
native1_300x100
lorem ipsum